Mergers And Acquisitions In The Global Pharmaceutical Industry

Author : Mennen
Publisher : GRIN Verlag
ISBN 13 : 3640779762
Total Pages : 30 pages
Book Rating : 4.65/5 ( download)

DOWNLOAD NOW!

Download or read book Mergers and Acquisitions in the Global Pharmaceutical Industry written by Mennen and published by GRIN Verlag. This book was released on 2010-12-17 with total page 30 pages. Available in PDF, EPUB and Kindle. Book excerpt: Project Report from the year 2006 in the subject Communications - Public Relations, Advertising, Marketing, Social Media, grade: 65 % - B, University of Sunderland, course: Global Corporate Strategy, language: English, abstract: Mergers and acquisitions are of major importance in the pharmaceutical industry. In order to evaluate the dynamics of this particular industry, this paper critically evaluates the pre- and post- merger situation of GlaxoSmithKline concerning its ready-access to markets, know-how and management capability. Furthermore, strengths and weaknesses and merger’s outcomes will be outlined. Critical push and pull factors affecting M&A activity in North America will be analysed, using Pfizer and Pharmacia as an example. In addition, general reasons for M&A failure in the pharmaceutical industry will be illustrated focussing on the M&A activity of GlaxoSmithKline. Finally, using two global pharmaceutical players (GSK and Astrazeneca), the merits and demerits of the McKinsey’s five step programme will be discussed.

Author : Mark Thomas
Publisher : Taylor & Francis
ISBN 13 : 1040008828
Total Pages : 211 pages
Book Rating : 4.29/5 ( download)

DOWNLOAD NOW!

Download or read book Mergers and Acquisitions written by Mark Thomas and published by Taylor & Francis. This book was released on 2024-04-05 with total page 211 pages. Available in PDF, EPUB and Kindle. Book excerpt: Covid-19 has brought so much uncertainty, but one certainty is that the vaccine race will generate winners and losers in the pharmaceutical and biotechnology industries. This will have a major impact on merger and acquisition activity. While the plethora of merger and acquisition deals are abundantly reported by the news media, there is a clear lack of in-depth analysis on the multiple rationales and various challenges in the life sciences industry. By offering contributions from a variety of experts in the biotechnology and pharmaceutical industries, as well as experts on mergers and acquisitions, this edited collection will draw upon the knowledge of a variety of different actors within the fields of pharma and biotech. This book offers a timely exploration of the complexities of mergers and acquisitions in the pharmaceutical and biotechnology industries while seeking to bridge the gap between theory and practice. It presents a critical analysis of the rationale for acquisitions and studies the challenges of ensuring a successful deal. In the light of the Covid-19 pandemic, it will also explore the impact this may have on the industry, which may further stimulate merger and acquisition activity. It will be of interest to researchers, academics, policymakers, and students in the fields of strategy, management, governance, and the biotechnology and pharmaceutical industries.

Author : R. D. Neirinckx
Publisher : Rudi Neirinckx
ISBN 13 : 186067464X
Total Pages : 201 pages
Book Rating : 4.48/5 ( download)

DOWNLOAD NOW!

Download or read book Mergers and Acquisitions in Pharmaceuticals - Why and How? written by R. D. Neirinckx and published by Rudi Neirinckx. This book was released on 2000-02 with total page 201 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Author : Martin Wenderoth
Publisher : GRIN Verlag
ISBN 13 : 3640267036
Total Pages : 19 pages
Book Rating : 4.33/5 ( download)

DOWNLOAD NOW!

Download or read book The merger of "sanofi-aventis" as an example for Reasons and Consequences of Mergers and Acquistions in the Pharmaceutical Industry written by Martin Wenderoth and published by GRIN Verlag. This book was released on 2009-02-13 with total page 19 pages. Available in PDF, EPUB and Kindle. Book excerpt: Essay from the year 2008 in the subject Business economics - Offline Marketing and Online Marketing, grade: (4) good, Eötvös Loránd Tudományegytem (International PhD Program), course: Business Economics, language: English, abstract: Within the ongoing globalisation process, many national markets and industrial branches are in different phases of the transition from local to global economic structures (Bryan, L.; Fraser, J.; Oppenheim, J. Rall, W., 2000, pp. 71-95). As a result of this development organisations in the different industries are increasingly concentrating (Brühl, V., 2003, pp. 274-278). Among other industries, also the pharmaceutical industry is highly influenced by the above mentioned trend, reflected by the increasing number of mergers and acquisitions (M&A’s) in the pharmaceutical industry, which is illustrated in the following figure. Figure 1: The present assignment is going to evaluate the reasons and consequences of M&A’s within the pharmaceutical industry by using the sanofi-aventis merger as an example. First of all, the recent history of sanofi-aventis is briefly described. The third part will describe the reasons and consequences of mergers and acquisitions in the pharmaceutical industry by describing the challenges the pharmaceutical branch is confronted with and the respective motives of and results from M&A activities. Finally, the major findings are summarised and conclusions will be derived. 2. History of sanofi-aventis Following the company homepage of sanofi-aventis (20071), the year 1999 has been very im-portant because of two reasons. First of all, Sanofi took over the Synthelabo Holding GmbH and changed its company name to Sanofi-Synthelabo. Furthermore, Hoechst merged with Rhône-Poulenc, a French chemical and pharmaceutical organisation in order to form the new company Aventis, with its legal seat in Strassbourgh (...)

Author : Management Association, Information Resources
Publisher : IGI Global
ISBN 13 : 1668438860
Total Pages : 1235 pages
Book Rating : 4.62/5 ( download)

DOWNLOAD NOW!

Download or read book Research Anthology on Measuring and Achieving Sustainable Development Goals written by Management Association, Information Resources and published by IGI Global. This book was released on 2021-12-30 with total page 1235 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Sustainable Development Goals are an ongoing focus around the world as the needs of people and society continue to evolve at a rapid pace. The need for a more sustainable future has never been more pressing as issues such as climate change, natural disasters, and overpopulation present unique difficulties for the decision makers of the world. In order for them to make the best decisions regarding current priorities and strategies, up-to-date and detailed research regarding where we currently are as a society, where we want to be, and the many challenges that stand in the way is crucial. The Research Anthology on Measuring and Achieving Sustainable Development Goals is a comprehensive assessment of the current innovative research and discussions on the challenges to achieving the UN’s Sustainable Development Goals and the measures that have already been put in place to achieve them. Covering topics such as green consumer behavior and peace promotion, this book is vital for academicians, scientists, researchers, students, postdoctoral students, specialists, practitioners, businesses, governmental institutions, decision makers, environmentalists, and policymakers.

Author : Jakob Miera
Publisher : GRIN Verlag
ISBN 13 : 3656515379
Total Pages : 92 pages
Book Rating : 4.71/5 ( download)

DOWNLOAD NOW!

Download or read book Mergers & Acquisitions in the Contract Research Organization Industry written by Jakob Miera and published by GRIN Verlag. This book was released on 2013-10-10 with total page 92 pages. Available in PDF, EPUB and Kindle. Book excerpt: Master's Thesis from the year 2013 in the subject Business economics - Business Management, Corporate Governance, grade: 1,0, , language: English, abstract: This thesis deals in general with mergers & acquisitions in the CRO industry, and more specifically with reasons for M&A, success factors during the M&A process, and why M&A can fail in the Contract Research Organization industry. The pharmaceutical industry faces increasing obstacles in respect to the development and introduction of new medications. That has to do with stricter requirements for admission and sharper controls by authorities. Today, the research and development of a new drug can easily consume more than $800 million and lasting between 10 and 15 years. Due to these admission, money and time pressures, pharmaceutical companies are looking for an alternative in the drug development process. A very popular alternative is the outsourcing or in-house working with Contract Research Organizations (CRO). Contract Research Organizations are specialized in coordination and monitoring of drug development activities. Due to their focus they often offer a more sophisticated and faster process. Demographic changes, chronic diseases like cancer and diabetes, and completely new cluster of symptoms demand new therapeutically treatments. The size of the CRO market in 2012 was around $32 billion and had an estimated market growth of around 9 – 12% for 2013. Increased outsourcing and allocation of R&D money towards CRO reflects a driving force for prospective growth. To benefit from the good industry outlooks CROs adjust their service offerings and strengthen their competitive situation. More and more Contract Research Organizations consider mergers & acquisitions as a vital solution to achieve their objectives. Since couple of years we can observe an increased number of deals. Large corporations can close the gaps in the internal service pipeline and smaller firms can use mergers as a financial exit. However, many M&A activities are considered as ineffective and contra-productive for the shareholder value – either destroy or merely add. Depending on the study, the numbers of M&A failures vary from 50% to even 80%. Possible reasons may be not enough integration planning and unrealistic expectations on the cost and time. The reality shows that it is not that easy to cut costs by simple combining two departments after a merger or acquisition. Additionally, we can see that mergers and acquisitions basically not succeed during the actual process.[...]

Author : Abdul Wajid
Publisher :
ISBN 13 :
Total Pages : 0 pages
Book Rating : 4.36/5 ( download)

DOWNLOAD NOW!

Download or read book Innovations Through Mergers and Acquisitions in the Pharmaceutical Sector written by Abdul Wajid and published by . This book was released on 2022 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Author : Cary L. Cooper
Publisher : Emerald Group Publishing
ISBN 13 : 1780521960
Total Pages : 189 pages
Book Rating : 4.61/5 ( download)

DOWNLOAD NOW!

Download or read book Advances in Mergers and Acquisitions written by Cary L. Cooper and published by Emerald Group Publishing. This book was released on 2012-01-02 with total page 189 pages. Available in PDF, EPUB and Kindle. Book excerpt: Focuses on the studies of the advances in mergers and acquisitions from scholars in different countries, with different research questions, relying on different theoretical perspectives. This title helps scholars think about mergers and acquisitions in different ways.

Author : Steven N. Kaplan
Publisher : University of Chicago Press
ISBN 13 : 0226424332
Total Pages : 350 pages
Book Rating : 4.30/5 ( download)

DOWNLOAD NOW!

Download or read book Mergers and Productivity written by Steven N. Kaplan and published by University of Chicago Press. This book was released on 2007-12-01 with total page 350 pages. Available in PDF, EPUB and Kindle. Book excerpt: Mergers and Productivity offers probing analyses of high-profile mergers in a variety of industries. Focusing on specific acquisitions, it illustrates the remarkable range of contingencies involved in any merger attempt. The authors clearly establish each merger's presumed objectives and the potential costs and benefits of the acquisition, and place it within the context of the broader industry. Striking conclusions that emerge from these case studies are that merger and acquisition activities were associated with technological or regulatory shocks, and that a merger's success or failure was dependent upon the acquirer's thorough understanding of the target, its corporate culture, and its workforce and wage structures prior to acquisition. Sifting through a wealth of carefully gathered evidence, these papers capture the richness, the complexity, and the economic intangibles inherent in contemporary merger activity in a way that large-scale studies of mergers cannot.

Author :
Publisher :
ISBN 13 :
Total Pages : 148 pages
Book Rating : 4.06/5 ( download)

DOWNLOAD NOW!

Download or read book Biotechnology Deals written by and published by . This book was released on 2005 with total page 148 pages. Available in PDF, EPUB and Kindle. Book excerpt: Inside the Minds: Biotechnology Deals is an authoritative, insider's perspective on the issues surrounding biotech deals, including mergers and acquisitions, collaborations, and the future of doing successful deals. Featuring lawyers, CEOs of funded biotech companies, and venture capitalists who invest in them, this book provides a broad, yet comprehensive overview of the art of doing successful deals from the experts themselves. From finding and capitalizing on opportunities to completing the deal, these authors articulate the finer points around doing biotech deals now and what will hold true into the future. The different niches represented and the breadth of perspectives presented enable readers to get inside some of the great legal minds of today as experts offer up their thoughts around the keys to success within this fascinating area.About Inside the Minds:Inside the Minds provides readers with proven business intelligence from C-Level executives (Chairman, CEO, CFO, CMO, Partner) from the world's most respected companies nationwide, rather than third-party accounts from unknown authors and analysts. Each chapter is comparable to an essay/thought leadership piece and is a future-oriented look at where an industry, profession or topic is headed and the most important issues for the future. Through an exhaustive selection process, each author was hand-picked by the Inside the Minds editorial board to author a chapter for this book.This book is by: Lee R. Brettman, M.D., FACP, Dynogen Pharmaceuticals, Inc.??Successful Strategies for Biotech Deals?Manish N Chapekar, Montreux Equity Partners??Building Successful Biotech Deals?Daniel Devine, Acceptys, Inc.??The Art of the Deal?Mark I. Gruhin, Schmeltzer, Aptaker & Shepard, PC??Mergers and Acquisitions, Collaborations, and Partnerships?James T. Gunton, NJTC Venture Fund??Strategies for Successful Deals?Johnny Humphreys, Gen Prime??Finding Success in Biotech?Roland H. Johnson, Piedmont Pharmaceuticals LLC??Making Your Way Through Biotech Dealings?Thomas G. Klopack, Self Employed, Former CEO of Aclara Biosciences??Keys to Success in Biotechnology?Gerard J. McGarrity, Ph.D., Intronn Inc.??Successful Biotech Deals?Mark Schwartz , Ph.D., Bayhill Therapeutics??Biotech Deal Strategies?Abhi-Shek Jain, WTP Capital, LLC??Secrets to Success?Alexis V. Lukianov, NuVasive, Inc.??Finding and Capitalizing on Opportunities?